STAT3 inhibition targets cytokine signaling and renal inflammation in systemic lupus erythematosus and lupus nephritis
New review suggests STAT3 inhibition could help lupus kidney disease
This narrative review examines the role of STAT3 in systemic lupus erythematosus and lupus nephritis. The authors argue that STAT3 integrate…
A narrative review suggests targeting STAT3 might treat lupus kidney inflammation, though direct drug targeting remains unproven in patients…
Narrative review explores microbiome-targeting therapies for inflammatory bowel disease patients
New microbial therapies for inflammatory bowel disease show promise
This narrative review examines the potential of targeting the microbial-metabolic axis for patients with inflammatory bowel disease. The aut…
A review explores how targeting the microbial-metabolic axis might help patients with inflammatory bowel disease using treatments like fecal…
Review of phage strategies for antimicrobial resistance and cancer-related infections
Virus Trucks Deliver Cancer Drugs While Fighting Superbugs
This narrative review examines phage-enabled strategies, tailored formulations, and engineered phages for treating antimicrobial resistance,…
• Engineered viruses now target tumors and kill drug-resistant bacteria • Patients with tough infections or hard-to-treat cancers could bene…